Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) EPS (Weighted Average and Diluted) (2019 - 2025)

AdaptHealth (AHCO) has 7 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.73 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 308.57% year-over-year to -$0.73; the TTM value through Dec 2025 reached -$0.52, down 185.25%, while the annual FY2025 figure was -$0.52, 185.25% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.73 in Q4 2025 per AHCO's latest filing, down from $0.16 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.4 in Q4 2021 and bottomed at -$3.43 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.21, with a median of $0.09 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 200.0% in 2022, then tumbled 9450.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.4 in 2021, then crashed by 105.0% to -$0.02 in 2022, then crashed by 9450.0% to -$1.91 in 2023, then soared by 118.32% to $0.35 in 2024, then crashed by 308.57% to -$0.73 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.73 in Q4 2025, $0.16 in Q3 2025, and $0.1 in Q2 2025.